Cryo Cell International (CCEL) Total Current Liabilities (2016 - 2025)
Cryo Cell International (CCEL) has disclosed Total Current Liabilities for 16 consecutive years, with $19.8 million as the latest value for Q4 2025.
- On a quarterly basis, Total Current Liabilities fell 8.36% to $19.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was $19.8 million, a 8.36% decrease, with the full-year FY2025 number at $19.8 million, down 8.36% from a year prior.
- Total Current Liabilities was $19.8 million for Q4 2025 at Cryo Cell International, up from $18.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $29.8 million in Q1 2021 to a low of $15.7 million in Q2 2022.
- A 5-year average of $20.2 million and a median of $19.8 million in 2023 define the central range for Total Current Liabilities.
- Peak YoY movement for Total Current Liabilities: surged 85.72% in 2021, then tumbled 45.09% in 2022.
- Cryo Cell International's Total Current Liabilities stood at $21.1 million in 2021, then decreased by 7.56% to $19.5 million in 2022, then increased by 7.1% to $20.9 million in 2023, then grew by 3.53% to $21.6 million in 2024, then decreased by 8.36% to $19.8 million in 2025.
- Per Business Quant, the three most recent readings for CCEL's Total Current Liabilities are $19.8 million (Q4 2025), $18.5 million (Q3 2025), and $21.8 million (Q2 2025).